The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks over ...

Triptans is a medication that can help relieve migraine symptoms. Research has found it effective, but it’s not for everyone. Migraine is a neurological condition affecting millions of people ...

Verapamil was more commonly used to prevent migraine attacks in the past, but it has never been FDA-approved for this purpose. Share on Pinterest Mads Perch/Getty Images Verapamil belongs to a ...

Atogepant, a recently approved drug for migraine, may start working as soon as day 1 of treatment, according to a recent study published in Neurology. "With many current drugs to prevent migraine, it ...

NEW YORK (Reuters) - Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other ...

Calcitonin gene-related peptide (CGRP) inhibitors are now considered a first-line treatment used to treat and prevent migraines. There are two types of CGRP medications: monoclonal antibodies and ...

But a recently approved daily migraine pill called Qulipta (atogepant) appears to be effective from day one in many patients, clinical trial data shows.

Expert Rev Clin Pharmacol. 2013;6(3):271-288. Triptans are highly effective for short-term treatment of acute migraine attacks. They are effective in MA or MO, but are not intended for use in ...

Amitriptyline has long been used for migraine prevention. Discover how this antidepressant works, its side effects, and why it's still being prescribed.

June 26, 2024 — A drug used to prevent migraine may also be effective in people with migraine who experience rebound headaches, according to a new ... Use of Acid Reflux Drugs Linked to Higher ...

Preventive antimigraine therapy (PAM) should probably not be considered until the headache frequency exceeds 1 per week. PAM is associated with significant side effects and often with ...

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology®. The study looked at the drug atogepant, ...